Serum biomarkers facilitate the recognition of early- stage cancer and may guide the selection of surgical candidates: A study of carcinoembryonic antigen and tissue polypeptide antigen in patients with operable non–small cell lung cancer
- 1 November 2001
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 122 (5) , 891-899
- https://doi.org/10.1067/mtc.2001.117622
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Revisions in the International System for Staging Lung CancerChest, 1997
- TUMOR MARKERS: An UpdateMedical Clinics of North America, 1996
- Clinical applications of serum markers for lung cancerRespiratory Medicine, 1995
- Serum tumour markers in lung cancer: history, biology and clinical applicationsEuropean Respiratory Journal, 1994
- Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancerLung Cancer, 1993
- Prognostic Value of the Tissue Polypeptide Antigen in Lung CancerChest, 1992
- Usefulness of Tissue Polypeptide Antigen in Staging, Monitoring, and Prognosis of Lung CancerChest, 1988
- Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9Cancer, 1987
- Clinical value of a multiple biomarker assay in patients with bronchogenic carcinomaCancer, 1986
- A New International Staging System for Lung CancerChest, 1986